RxDoctor Payments Data

Brian Pratt, MD

Family Medicine · Clayton, GANPI 1679861256

Payments from drug & device makers

$29,604in general payments, 2019–2025

Across 416 payments — averaging $71.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Indivior Inc.$10K
  • AbbVie$9K
  • Eli Lilly$5K
  • Novo Nordisk$1K
  • Bayer$577
  • Lilly USA, LLC$562
  • plus $3K from 37 others

What the payments were for

  • Consulting fees$5,47518%
  • Speaking & faculty fees$13,92347%
  • Travel & lodging$2,3588%
  • Food & beverage$7,80126%
  • Education$470%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$29,604 in reported general payments places this provider in the 95th percentile of 3,111 family medicine providers in Georgia.

See all family medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$280,526
Medicare patients
228
Services billed
8,806

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide119$149,264
MounjaroTirzepatide82$95,034
FarxigaDapagliflozin Propanediol73$85,231
EliquisApixaban65$83,205
VraylarCariprazine Hcl51$69,269
ZenpepLipase/Protease/Amylase13$57,155
XareltoRivaroxaban28$39,569
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl457$37,095
KerendiaFinerenone26$35,639
JardianceEmpagliflozin25$34,309
Xtampza ErOxycodone Myristate41$30,182
LinzessLinaclotide30$29,907
Breztri AerosphereBudesonide/Glycopyr/Formoterol23$24,985
Gvoke Hypopen 2-PackGlucagon15$19,662
EntrestoSacubitril/Valsartan15$18,086

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$1,009$149,264119 claims
AstraZenecaFarxiga, Breztri Aerosphere$236$110,21696 claims
Lilly USA, LLCMounjaro, Trulicity$562$109,01896 claims
AbbVieVraylar, Linzess$9,445$99,17581 claims
PfizerEliquis, Abrysvo$221$90,55088 claims
Johnson & JohnsonXarelto$65$39,56928 claims
BayerKerendia$577$35,63926 claims
Boehringer IngelheimJardiance$149$34,30925 claims
NovartisEntresto$247$18,08615 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$116$11,99413 claims
Indivior Inc.Suboxone$9,814$9,28029 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,111 family medicine providers in Georgia.

Other family medicine in Clayton

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →